Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank67
3Y CAGR+27.0%
5Y CAGR+52.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+27.0%/yr
Annual compound
5Y CAGR
+52.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
8.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.88M | -58.3% |
| 2024 | $11.69M | +33.3% |
| 2023 | $8.77M | +268.2% |
| 2022 | $2.38M | +102.9% |
| 2021 | $-81.02M | -13902.7% |
| 2020 | $587000.00 | +675.5% |
| 2019 | $-102000.00 | - |